AI Quick Summary

🔍 Meet the residents across our SI Parks ! 🔎@Worg Pharmaceuticals has opted to establish its European headquarters at the site Allschwil of the @SIP Basel. The Chinese biopharmaceutical company, founded in 2018, develops innovative therapies to treat #allergies and #autoimmune diseases 🔬💉Business activities in Europe include both drug discovery and the preclinical and clinical development. The goal is to establish extensive research collaborations with academic institutions across Europe.“Right from the very start we received incredible support from the management of the Switzerland Innovation Park as well as from experienced law firms and auditors. This enabled our company to get off to a smooth start,” says Rainer Henning, Director of Science at Worg Pharma’s hub of business activities in Europe. ❓ Find out why Worgpharma chose the Switzerland Innovation Park Basel Area for the opening of its R&D center: https://www.switzerland-innovation.com/node/435 Worgpharma recently announced the completion of over CNY 1.1 billion in Series C financing. This represents the equivalent of 130 million Swiss francs 📰 Learn more in the news article: https://www.s-ge.com/en/article/news/20233-life-science-worg-pharma-financing-round #SwitzerlandInnovation #whyswitzerland #openinnovation #lifesciences #openinnovation #biotech #pharma #preclinical #clinical

Post Metadata

• Author: Switzerland Innovation Digital
• Published Date: 5/17/2024 10:41:06 AM
• Modified Date: 9/24/2024 12:29:54 PM

Post Description

🔍 Meet the residents across our SI Parks ! 🔎

@Worg Pharmaceuticals has opted to establish its European headquarters at the site Allschwil of the @SIP Basel. The Chinese biopharmaceutical company, founded in 2018, develops innovative therapies to treat #allergies and #autoimmune diseases 🔬💉

Business activities in Europe include both drug discovery and the preclinical and clinical development. The goal is to establish extensive research collaborations with academic institutions across Europe.

“Right from the very start we received incredible support from the management of the Switzerland Innovation Park as well as from experienced law firms and auditors. This enabled our company to get off to a smooth start,” says Rainer Henning, Director of Science at Worg Pharma’s hub of business activities in Europe.

❓ Find out why Worgpharma chose the Switzerland Innovation Park Basel Area for the opening of its R&D center: https://www.switzerland-innovation.com/node/435

Worgpharma recently announced the completion of over CNY 1.1 billion in Series C financing. This represents the equivalent of 130 million Swiss francs

📰 Learn more in the news article: https://www.s-ge.com/en/article/news/20233-life-science-worg-pharma-financing-round

#SwitzerlandInnovation #whyswitzerland #openinnovation #lifesciences #openinnovation #biotech #pharma #preclinical #clinical